NAD+ Direct: IV, Subcutaneous, and the Question of Whether You Need Any of It

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in essentially every redox reaction in your cells. It is central to mitochondrial function, sirtuin signaling, and DNA repair. NAD+ levels decline with age, and that decline has been associated with a long list of age-related conditions. Whether directly raising NAD+ in adults reverses any of that meaningfully in humans is the active question.

What it does

Inside the cell, NAD+ accepts electrons during energy production and is consumed by enzymes including PARPs and sirtuins. Direct supplementation routes include IV infusion (popular in clinics, expensive), subcutaneous injection, and intranasal formulations. Whether large-molecule NAD+ crosses cell membranes efficiently or is broken down to precursors first is genuinely debated; precursor approaches (NMN, NR, NADH) bypass that question.

Typical protocol shape

Common patterns include:

• IV infusion over hours, often on a loading schedule (e.g., several sessions over two weeks), then maintenance
• Subcutaneous injection in smaller daily or alternate-day doses
• Combination with precursor oral supplements

IV infusions in particular are uncomfortable for many people, with chest pressure and nausea during fast infusion. Slowing the rate usually fixes that.

What to track daily

• Route, dose, and time
• Subjective energy on a 1 to 10 scale
• Sleep duration and quality
• Mood and cognitive clarity
• Any flushing, nausea, or pressure during dosing

What to track weekly

• Average daily energy
• Exercise capacity at a fixed workload
• Recovery between training sessions
• Body weight
• Skin and hair changes (often reported anecdotally)

Bloodwork worth doing

• Complete blood count
• Comprehensive metabolic panel
• Liver function tests
• Inflammatory markers
• If you can find it, direct NAD+ measurement, though assay quality varies and reference ranges are not standardized

Realistic expectations

Some users report meaningful subjective benefit in the first weeks; controlled trials of direct IV NAD+ at the doses clinics use are limited, expensive to run, and have produced mixed signals. The effects most reliably reported in literature involve precursor supplementation in specific populations rather than IV NAD+ in healthy adults.

Common mistakes

• Paying for IV NAD+ without a baseline of energy, sleep, and performance to compare against
• Assuming subjective benefit equals biological benefit
• Running the protocol fast enough to feel sick, then attributing the sickness to "detox"
• Ignoring cheaper precursor routes that may produce similar measurable changes
• Continuing indefinitely without an off-period to test reversibility

A tracking template

In Peptide IA, log each infusion or injection with route, dose, and a comfort score during dosing. Track daily energy and sleep, and weekly performance at a fixed task. The honest test is whether your numbers change in a way you would not have predicted from training and sleep alone.

Bottom line

Direct NAD+ supplementation is expensive and the human evidence is thinner than the marketing suggests. If you try it, design it as an experiment, not a subscription.

Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.